Hotchkis & Wiley Capital Management LLC grew its holdings in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 152.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 2,048,440 shares of the company’s stock after buying an additional 1,237,620 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned approximately 2.87% of SIGA Technologies worth $13,827,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the business. Larson Financial Group LLC bought a new position in shares of SIGA Technologies during the third quarter valued at approximately $30,000. DekaBank Deutsche Girozentrale bought a new position in SIGA Technologies in the 2nd quarter worth $40,000. AQR Capital Management LLC purchased a new stake in shares of SIGA Technologies in the 2nd quarter worth about $99,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of SIGA Technologies by 38.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock valued at $104,000 after purchasing an additional 3,829 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its position in shares of SIGA Technologies by 64.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock valued at $93,000 after buying an additional 5,372 shares during the period. 55.40% of the stock is currently owned by institutional investors.
SIGA Technologies Price Performance
Shares of SIGA opened at $6.64 on Wednesday. The company has a 50-day simple moving average of $6.92 and a two-hundred day simple moving average of $7.84. The firm has a market capitalization of $474.10 million, a PE ratio of 5.53 and a beta of 0.89. SIGA Technologies, Inc. has a one year low of $4.26 and a one year high of $12.83.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than SIGA Technologies
- Trading Halts Explained
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Netflix Is On Track To Hit $1,000 By Christmas
- How is Compound Interest Calculated?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report).
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.